TWM
AIFF

Trueblood Wealth Management’s Firefly Neuroscience AIFF Stock Holding History

Trueblood Wealth Management’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,333
Closed -$33.1K – 236
2024
Q2 		$33.1K Hold
5,333
– – 0.02% 218
2024
Q1 		$55.4K Hold
5,333
– – 0.03% 223
2023
Q4 		$27K Buy
+5,333
New +$34.6K 0.02% 207

Other funds holding AIFF

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Trueblood Wealth Management's AIFF Position: Q3 2024 in Review

Trueblood Wealth Management sold out of Firefly Neuroscience (AIFF) in Q3 2024, closing a stake of 5,333 shares — an estimated $33.1K sold.

Trueblood Wealth Management first reported a position in AIFF in Q4 2023 and held it in 3 quarters. The position peaked at $55.4K in Q1 2024. 9 funds tracked by Wall St. Rank hold AIFF as of Q3 2024.

  • Trueblood Wealth Management reported no remaining Firefly Neuroscience position as of Q3 2024 after selling out during the quarter.
  • Trueblood Wealth Management sold 5,333 Firefly Neuroscience shares in Q3 2024, an estimated $33.1K.
  • Trueblood Wealth Management first reported a position in Firefly Neuroscience in Q4 2023 and held it in 3 quarters.
  • Trueblood Wealth Management's Firefly Neuroscience position peaked at $55.4K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2024.

Based on Trueblood Wealth Management's 13F filing for Q3 2024, filed 23 Oct 2024.